May 15, 202443 words
Published: May 15, 2024 | 43 words
Atossa Therapeutics CEO Dr Steven Quay joined Steve Darling from Proactive to share news the company has been granted, by the U.S. Patent office, a new patent directed to enterically encapsulated Endoxifen compositions formulated as a suspension. These will include all liquid sus...
CRITIC REVIEWS
There don't seem to be any reviews yet.
PUBLIC REVIEWS
There don't seem to be any reviews yet.